(Q38010557)

26 August 2017

The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials (English)

1 reference

26 August 2017

1 reference

1 reference

Eduardo Lopez-Huertas

series ordinal

1

1 reference

26 August 2017

1 June 2012

1 reference

British Journal of Nutrition

26 August 2017

1 reference

26 August 2017

107 Suppl 2

1 reference

26 August 2017

S185-94

1 reference

Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia

26 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Dyslipidemia of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Clinical relevance of postprandial lipaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Atherogenesis: a postprandial phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effects of dietary fat modification on skeletal muscle fatty acid handling in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation - insights from the LIPGENE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Fish oil supplementation in type 2 diabetes: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Fish oil and glycemic control in diabetes. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Effect of the dietary fat quality on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Fatty acids and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Comparative effects of DHA and EPA on cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Lipoprotein atherogenicity: an overview of current mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Low-density lipoprotein size and cardiovascular risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentratio...

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

A Low-Fat, High-Complex Carbohydrate Diet Supplemented with Long-Chain (n-3) Fatty Acids Alters the Postprandial Lipoprotein Profile in Patients with Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

The inverse relation between fish consumption and 20-year mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Acute ingestion of long-chain (n-3) polyunsaturated fatty acids decreases fibrinolysis in men with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Are there specific treatments for the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

n-3 fatty acids and serum lipoproteins: human studies

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Fish consumption and the 30-year risk of fatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Distribution, interconversion, and dose response of n-3 fatty acids in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001572

7 January 2021

10.1017/S0007114512001572

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22591892